| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.70B | 150.61B | 143.29B | 129.51B | 76.17B | 73.95B |
| Gross Profit | 69.07B | 82.28B | 67.40B | 64.44B | 53.72B | 64.25B |
| EBITDA | 28.79B | 29.57B | 36.39B | 33.81B | 20.91B | 23.19B |
| Net Income | 18.92B | 22.75B | 23.98B | 23.53B | 15.56B | 13.92B |
Balance Sheet | ||||||
| Total Assets | 3.21T | 3.23T | 3.02T | 3.04T | 2.95T | 2.96T |
| Cash, Cash Equivalents and Short-Term Investments | 246.36B | 609.23B | 821.55B | 299.57B | 539.10B | 422.44B |
| Total Debt | 129.70B | 499.29B | 242.35B | 235.16B | 204.24B | 223.64B |
| Total Liabilities | 3.01T | 3.05T | 2.82T | 2.85T | 2.76T | 2.75T |
| Stockholders Equity | 192.55B | 177.57B | 184.97B | 185.33B | 177.83B | 198.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.56B | 61.42B | 35.42B | 22.02B | 100.75B |
| Operating Cash Flow | 0.00 | 11.04B | 65.31B | 39.11B | 26.43B | 104.31B |
| Investing Cash Flow | 0.00 | -209.82B | -76.56B | -62.91B | -34.48B | 27.54B |
| Financing Cash Flow | 0.00 | 168.90B | -26.46B | -17.56B | -6.29B | -10.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £205.69B | 12.10 | 8.88% | 4.27% | -11.86% | -24.31% | |
68 Neutral | £10.56B | 3.32 | 12.75% | 6.78% | -2.34% | 2.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £54.08B | 10.47 | 8.08% | 3.41% | -22.85% | -21.12% | |
65 Neutral | £34.50B | 11.02 | 9.85% | 1.70% | -4.35% | 21.86% | |
64 Neutral | £42.66B | 9.00 | 14.96% | 3.85% | 4.27% | 26.21% | |
61 Neutral | £52.96B | 9.37 | 9.41% | 1.50% | 14.18% | 46.12% |